Cargando…

Incorporating genomics into breast and prostate cancer screening: assessing the implications

Individual risk prediction and stratification based on polygenic profiling may be useful in disease prevention. Risk-stratified population screening based on multiple factors including a polygenic risk profile has the potential to be more efficient than age-stratified screening. In this article, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chowdhury, Susmita, Dent, Tom, Pashayan, Nora, Hall, Alison, Lyratzopoulos, Georgios, Hallowell, Nina, Hall, Per, Pharoah, Paul, Burton, Hilary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941015/ https://www.ncbi.nlm.nih.gov/pubmed/23412607 http://dx.doi.org/10.1038/gim.2012.167

Ejemplares similares

Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling?
por: Chowdhury, Susmita, et al.
Publicado: (2015)

Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues
por: Hall, A.E., et al.
Publicado: (2014)

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
por: Pashayan, N, et al.
Publicado: (2011)

Public health genomics and personalized prevention: lessons from the COGS project
por: Pashayan, N, et al.
Publicado: (2013)

Life insurance: genomic stratification and risk classification
por: Joly, Yann, et al.
Publicado: (2014)

Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertility
por: Pashayan, Nora, et al.
Publicado: (2006)

Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
por: Callender, Tom, et al.
Publicado: (2019)

Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer
por: Callender, Thomas, et al.
Publicado: (2021)

Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening
por: Pashayan, N, et al.
Publicado: (2009)

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
por: Pashayan, Nora, et al.
Publicado: (2015)

Cost effectiveness of the NHS breast screening programme: life table model
por: Pharoah, Paul D P, et al.
Publicado: (2013)

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model
por: Pashayan, Nora, et al.
Publicado: (2018)

Risk-Stratified Breast Cancer Screening Incorporating a Polygenic Risk Score: A Survey of UK General Practitioners’ Knowledge and Attitudes
por: Ayoub, Aya, et al.
Publicado: (2023)

Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study
por: Warren-Gash, Charlotte, et al.
Publicado: (2016)

When evidence says no: gynaecologists’ reasons for (not) recommending ineffective ovarian cancer screening
por: Wegwarth, Odette, et al.
Publicado: (2020)

A Systematic Review and Critical Assessment of Breast Cancer Risk Prediction Tools Incorporating a Polygenic Risk Score for the General Population
por: Mbuya-Bienge, Cynthia, et al.
Publicado: (2023)

Of Screening, Stratification, and Scores
por: Knoppers, Bartha M., et al.
Publicado: (2021)

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC
por: Pashayan, Nora, et al.
Publicado: (2015)

The cost-effectiveness of risk-stratified breast cancer screening in the UK
por: Hill, Harry, et al.
Publicado: (2023)

Breast, Prostate, Colorectal, and Lung Cancer Incidence and Risk Factors in Women Who Have Sex with Women and Men Who Have Sex with Men: A Cross-Sectional and Longitudinal Analysis Using UK Biobank
por: Underwood, Sarah, et al.
Publicado: (2023)

Personalised medicine in the UK: challenges of implementation and impact on healthcare system
por: Pokorska-Bocci, Anna, et al.
Publicado: (2014)

Ethical and legal implications of implementing risk algorithms for early detection and screening for oesophageal cancer, now and in the future
por: Brigden, Tanya, et al.
Publicado: (2023)

Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications
por: Agnarelli, Alessandro, et al.
Publicado: (2022)

Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population
por: Rochester, Mark A, et al.
Publicado: (2009)

Post-sampling mortality and non-response patterns in the English Cancer Patient Experience Survey: Implications for epidemiological studies based on surveys of cancer patients
por: Abel, Gary A., et al.
Publicado: (2016)

Incorporation of biological knowledge into distance for clustering genes
por: Boratyn, Grzegorz M, et al.
Publicado: (2007)

Systematic Review and Narrative Synthesis of Economic Evaluations of Prostate Cancer Diagnostic Pathways Incorporating Prebiopsy Magnetic Resonance Imaging
por: Merriel, Samuel W.D., et al.
Publicado: (2023)

Prostate Cancer Screening: A Brief Tool to Incorporate Patient Preferences in a Clinical Encounter
por: Misra-Hebert, Anita D., et al.
Publicado: (2016)

Incorporating Method Dissatisfaction into Unmet Need for Contraception: Implications for Measurement and Impact
por: Rothschild, Claire W., et al.
Publicado: (2021)

Nuffield Council on Bioethics Report: Novel Techniques for the prevention of mitochondrial DNA disorders: an ethical review London: Nuffield Council of Bioethics 2012
por: Hallowell, Nina
Publicado: (2012)

Prevention in the age of personal responsibility: epigenetic risk-predictive screening for female cancers as a case study
por: Bolt, Ineke, et al.
Publicado: (2021)

Ceramide in the prostate
por: Dent, Paul
Publicado: (2013)

A toolkit for incorporating genetics into mainstream medical services: Learning from service development pilots in England
por: Bennett, Catherine L, et al.
Publicado: (2010)

Providing recurrence risk counselling for parents after diagnosis of a serious genetic condition caused by an apparently de novo mutation in their child: a qualitative investigation of the PREGCARE strategy with UK clinical genetics practitioners
por: Kay, Alison C, et al.
Publicado: (2023)

Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis
por: Xiong, Tengbin, et al.
Publicado: (2014)

Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening
por: Strand, Fredrik, et al.
Publicado: (2018)

A Clinical Risk Model for Personalized Screening and Prevention of Breast Cancer
por: Eriksson, Mikael, et al.
Publicado: (2023)

Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK
por: Meisel, Susanne F., et al.
Publicado: (2015)

Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer
por: Mittmann, Nicole, et al.
Publicado: (2022)

Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia
por: Pashayan, N, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_tv1o5jvcv4ppsht6nlb7lfum29